MetLife Investment Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.7M | Sell |
57,789
-2,661
| -4% | -$553K | 0.06% | 302 |
|
|
2026
Q1 | $12.8M | Sell |
60,450
-2,305
| -4% | -$496K | 0.07% | 295 |
|
|
2025
Q4 | $12.9M | Sell |
62,755
-2,166
| -3% | -$408K | 0.06% | 287 |
|
|
2025
Q3 | $10.2M | Sell |
64,921
-1,465
| -2% | -$226K | 0.05% | 357 |
|
|
2025
Q2 | $11.2M | Sell |
66,386
-2,686
| -4% | -$399K | 0.07% | 286 |
|
|
2025
Q1 | $9.52M | Sell |
69,072
-1,382
| -2% | -$176K | 0.05% | 350 |
|
|
2024
Q4 | $8.33M | Buy |
70,454
+471
| +0.7% | +$55K | 0.05% | 322 |
|
|
2024
Q3 | $7.73M | Sell |
69,983
-1,688
| -2% | -$176K | 0.04% | 333 |
|
|
2024
Q2 | $7.05M | Buy |
71,671
+9,436
| +15% | +$962K | 0.04% | 338 |
|
|
2024
Q1 | $6.96M | Sell |
62,235
-2,797
| -4% | -$302K | 0.05% | 339 |
|
|
2023
Q4 | $6.56M | Sell |
65,032
-3,380
| -5% | -$335K | 0.05% | 336 |
|
|
2023
Q3 | $5.94M | Sell |
68,412
-1,772
| -3% | -$160K | 0.05% | 340 |
|
|
2023
Q2 | $6.64M | Buy |
70,184
+3,700
| +6% | +$313K | 0.05% | 329 |
|
|
2023
Q1 | $5.02M | Sell |
66,484
-1,969
| -3% | -$149K | 0.04% | 440 |
|
|
2022
Q4 | $5.26M | Sell |
68,453
-3,856
| -5% | -$293K | 0.04% | 406 |
|
|
2022
Q3 | $4.82M | Sell |
72,309
-1,077
| -1% | -$68.3K | 0.04% | 425 |
|
|
2022
Q2 | $3.84M | Sell |
73,386
-9,334
| -11% | -$530K | 0.03% | 586 |
|
|
2022
Q1 | $4.69M | Buy |
82,720
+20,463
| +33% | +$1.1M | 0.03% | 573 |
|
|
2021
Q4 | $3.21M | Sell |
62,257
-3,275
| -5% | -$161K | 0.03% | 647 |
|
|
2021
Q3 | $3.24M | Sell |
65,532
-1,737
| -3% | -$94.2K | 0.03% | 593 |
|
|
2021
Q2 | $3.84M | Sell |
67,269
-2,711
| -4% | -$158K | 0.03% | 537 |
|
|
2021
Q1 | $4.25M | Sell |
69,980
-1,278
| -2% | -$70.5K | 0.04% | 473 |
|
|
2020
Q4 | $3.82M | Sell |
71,258
-2,889
| -4% | -$150K | 0.04% | 490 |
|
|
2020
Q3 | $3.48M | Sell |
74,147
-2,217
| -3% | -$114K | 0.04% | 461 |
|
|
2020
Q2 | $3.99M | Buy |
76,364
+972
| +1% | +$50.1K | 0.05% | 392 |
|
|
2020
Q1 | $3.61M | Sell |
75,392
-2,307
| -3% | -$120K | 0.05% | 360 |
|
|
2019
Q4 | $3.93M | Sell |
77,699
-3,434
| -4% | -$177K | 0.04% | 473 |
|
|
2019
Q3 | $3.83M | Sell |
81,133
-1,023
| -1% | -$46.7K | 0.04% | 467 |
|
|
2019
Q2 | $3.87M | Sell |
82,156
-2,558
| -3% | -$118K | 0.04% | 478 |
|
|
2019
Q1 | $4.08M | Sell |
84,714
-490
| -0.6% | -$24.5K | 0.04% | 441 |
|
|
2018
Q4 | $3.8M | Sell |
85,204
-4,637
| -5% | -$242K | 0.05% | 395 |
|
|
2018
Q3 | $4.85M | Sell |
89,841
-1,617
| -2% | -$82.8K | 0.05% | 368 |
|
|
2018
Q2 | $4.47M | Sell |
91,458
-3,249
| -3% | -$184K | 0.05% | 359 |
|
|
2018
Q1 | $5.94M | Sell |
94,707
-2,634
| -3% | -$181K | 0.07% | 265 |
|
|
2017
Q4 | $5.96M | Buy |
+97,341
| New | +$6.02M | 0.07% | 274 |
|
Other funds holding CAH
MetLife Investment Management's CAH Position: Q2 2026 in Review
MetLife Investment Management reduced its Cardinal Health (CAH) stake by 4.4% in Q2 2026, selling an estimated $553K and leaving 57,789 shares worth $13.7M. The position accounts for 0.06% of the portfolio, ranked #302.
MetLife Investment Management first reported a position in CAH in Q4 2017 and has held it in 35 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- MetLife Investment Management held 57,789 shares of Cardinal Health worth $13.7M as of Q2 2026.
- MetLife Investment Management sold 2,661 Cardinal Health shares in Q2 2026, an estimated $553K.
- Cardinal Health made up 0.06% of MetLife Investment Management's portfolio in Q2 2026, its #302 holding.
- MetLife Investment Management first reported a position in Cardinal Health in Q4 2017 and has held it in 35 quarters since.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.